22-29286712-A-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005243.4(EWSR1):​c.582-211A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.224 in 121,204 control chromosomes in the GnomAD database, including 3,002 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.22 ( 3002 hom., cov: 26)

Consequence

EWSR1
NM_005243.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.72
Variant links:
Genes affected
EWSR1 (HGNC:3508): (EWS RNA binding protein 1) This gene encodes a multifunctional protein that is involved in various cellular processes, including gene expression, cell signaling, and RNA processing and transport. The protein includes an N-terminal transcriptional activation domain and a C-terminal RNA-binding domain. Chromosomal translocations between this gene and various genes encoding transcription factors result in the production of chimeric proteins that are involved in tumorigenesis. These chimeric proteins usually consist of the N-terminal transcriptional activation domain of this protein fused to the C-terminal DNA-binding domain of the transcription factor protein. Mutations in this gene, specifically a t(11;22)(q24;q12) translocation, are known to cause Ewing sarcoma as well as neuroectodermal and various other tumors. Alternative splicing of this gene results in multiple transcript variants. Related pseudogenes have been identified on chromosomes 1 and 14. [provided by RefSeq, Jul 2009]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BP6
Variant 22-29286712-A-T is Benign according to our data. Variant chr22-29286712-A-T is described in ClinVar as [Benign]. Clinvar id is 1248405.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.384 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EWSR1NM_005243.4 linkc.582-211A>T intron_variant Intron 6 of 16 ENST00000397938.7 NP_005234.1 Q01844-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EWSR1ENST00000397938.7 linkc.582-211A>T intron_variant Intron 6 of 16 1 NM_005243.4 ENSP00000381031.2 Q01844-1

Frequencies

GnomAD3 genomes
AF:
0.223
AC:
27061
AN:
121114
Hom.:
3000
Cov.:
26
show subpopulations
Gnomad AFR
AF:
0.270
Gnomad AMI
AF:
0.0376
Gnomad AMR
AF:
0.215
Gnomad ASJ
AF:
0.184
Gnomad EAS
AF:
0.400
Gnomad SAS
AF:
0.392
Gnomad FIN
AF:
0.198
Gnomad MID
AF:
0.219
Gnomad NFE
AF:
0.182
Gnomad OTH
AF:
0.217
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.224
AC:
27091
AN:
121204
Hom.:
3002
Cov.:
26
AF XY:
0.228
AC XY:
13296
AN XY:
58194
show subpopulations
African (AFR)
AF:
0.270
AC:
8577
AN:
31728
American (AMR)
AF:
0.215
AC:
2529
AN:
11754
Ashkenazi Jewish (ASJ)
AF:
0.184
AC:
543
AN:
2956
East Asian (EAS)
AF:
0.400
AC:
1737
AN:
4342
South Asian (SAS)
AF:
0.390
AC:
1569
AN:
4018
European-Finnish (FIN)
AF:
0.198
AC:
1352
AN:
6816
Middle Eastern (MID)
AF:
0.212
AC:
48
AN:
226
European-Non Finnish (NFE)
AF:
0.182
AC:
10339
AN:
56916
Other (OTH)
AF:
0.222
AC:
367
AN:
1650
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
939
1877
2816
3754
4693
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
298
596
894
1192
1490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0457
Hom.:
42

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 18, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.14
DANN
Benign
0.13
PhyloP100
-2.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs5997462; hg19: chr22-29682701; API